Related Experiment Video

Updated: Sep 25, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)

Published on: April 24, 2017

Surgical treatment of mitral insufficiency secondary to coronary artery disease

J H Kay, P Zubiate, M A Mendez

    The Journal of Thoracic and Cardiovascular Surgery
    |January 1, 1980
    PubMed

    Insights

    This study on coronary artery disease patients with mitral insufficiency found that combining mitral valve repair with myocardial revascularization offers good long-term survival and low complication rates.

    Area of Science:

    • Cardiology
    • Cardiac Surgery
    • Cardiovascular Research

    Background:

    • Mitral insufficiency secondary to coronary artery disease (CAD) significantly impacts patient prognosis.
    • Patients with severe CAD and mitral insufficiency often present with advanced heart failure (New York Heart Association Class III/IV).
    • Preoperative assessment frequently reveals elevated left ventricular end-diastolic pressure and pulmonary artery pressure.

    Purpose of the Study:

    • To evaluate the outcomes of surgical intervention for mitral insufficiency in patients with coronary artery disease.
    • To assess the efficacy of combined mitral valve repair and myocardial revascularization.
    • To determine the long-term survival and complication rates associated with these procedures.

    Main Methods:

    • Retrospective analysis of 61 patients undergoing surgery for mitral insufficiency secondary to CAD between 1970 and 1978.
    • Procedures included myocardial revascularization, mitral valve repair, and mitral valve replacement.
    • Patient data included New York Heart Association classification, hemodynamic measurements, ejection fraction, and outcomes.

    Main Results:

    • The study included 61 patients (age 44-71) with severe mitral insufficiency and CAD.
    • Overall hospital mortality was low (5/61 patients).
    • Survival after mitral valve repair and myocardial revascularization was 81% at 7 years, with a low incidence of peripheral embolization (0.5% per patient-year).

    Conclusions:

    • Surgical management, particularly mitral valve repair combined with myocardial revascularization, is effective for patients with mitral insufficiency secondary to CAD.
    • This combined approach offers favorable long-term survival and a low risk of complications such as peripheral embolization.
    • The findings support the consideration of valve repair alongside revascularization in selected patients.

    More Related Videos

    A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair08:31

    A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

    Published on: October 16, 2021

    Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

    Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

    Published on: May 26, 2023

    Related Concept Videos

    Mitral Valve Prolapse II: Assessment and Management01:22

    Mitral Valve Prolapse II: Assessment and Management

    IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
    Mitral Regurgitation III: Medical Management01:25

    Mitral Regurgitation III: Medical Management

    Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
    Mitral Stenosis I: Introduction01:22

    Mitral Stenosis I: Introduction

    Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
    Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

    Mitral Stenosis II: Clinical features and Diagnostic Tests

    Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
    Mitral Stenosis III: Medical Management01:26

    Mitral Stenosis III: Medical Management

    Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...